Browsing byAuthorAbernethy, A

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)
2013The caregiving perspective in heart failure: a population based studyDavidson, P; Abernethy, A; Newton, P; Clark, K; Currow, D
2013-03-01Chronic refractory dyspnoea: Evidence based managementWiseman, R; Rowett, D; Allcroft, P; Abernethy, A; Currow, D
2013-11-01Evidence-based intervention for chronic refractory breathlessness: Practical therapies that make a differenceCurrow, D; Johnson, M; White, P; Abernethy, A
2015-09-01Indicators of integration of oncology and palliative care programs: An international consensusHui, D; Bansal, S; Strasser, F; Morita, T; Caraceni, A; Davis, M; Cherny, N; Kaasa, S; Currow, D; Abernethy, A; Nekolaichuk, C; Bruera, E
2015-01-01Low-dose opioids should be considered for symptom relief also in advanced chronic obstructive pulmonary disease (COPD)Ekström, M; Bornefalk-Hermansson, A; Abernethy, A; Currow, D
2016-11-25Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapyEkström, M; Ahmadi, Z; Bornefalk-Hermansson, A; Abernethy, A; Currow, D
2015-09-01Results From Phase III Trials of Anamorelin in Advanced Non-Small Cell Lung Cancer Patients with Cachexia: ROMANA 1 and 2Abernethy, A; Fearon, K; Friend, J; Yan, Y; Duus, E; Currow, D
2017-08-01ROMANA 3: A phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexiaCurrow, D; Temel, JS; Abernethy, A; Milanowski, J; Friend, J; Fearon, KC
2011-08-30Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease.Uronis, H; McCrory, DC; Samsa, G; Currow, D; Abernethy, A